-
1
-
-
0346461651
-
Electrophysiological interactions between striatal glutamatergic and dopaminergic systems
-
West AR, Floresco SB, Charara A, Rosenkranz JA, Grace AA: Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann NY Acad Sci 2003; 1003:53-74
-
(2003)
Ann NY Acad Sci
, vol.1003
, pp. 53-74
-
-
West, A.R.1
Floresco, S.B.2
Charara, A.3
Rosenkranz, J.A.4
Grace, A.A.5
-
2
-
-
84973986000
-
Neuroleptics and operant behavior: The anhedonia hypothesis
-
Wise RA: Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 1982; 5:39-87
-
(1982)
Behav Brain Sci
, vol.5
, pp. 39-87
-
-
Wise, R.A.1
-
3
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DA, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223
-
(2005)
N Engl J Med
, vol.353
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.A.6
Keefe, R.S.E.7
Davis, S.M.8
Davis, C.E.9
Lebowitz, B.D.10
Severe, J.11
Hsiao, J.K.12
-
4
-
-
0023873890
-
Significance of neuroleptic dose and plasma level in the pharmacologic treatment of psychoses
-
Baldessarini RJ, Cohen BM, Teicher MH: Significance of neuroleptic dose and plasma level in the pharmacologic treatment of psychoses. Arch Gen Psychiatry 1988; 45:79-91
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 79-91
-
-
Baldessarini, R.J.1
Cohen, B.M.2
Teicher, M.H.3
-
5
-
-
0035139761
-
Incentive-sensitization and addiction
-
Robinson TE, Berridge KC: Incentive-sensitization and addiction. Addiction 2001; 96:103-114
-
(2001)
Addiction
, vol.96
, pp. 103-114
-
-
Robinson, T.E.1
Berridge, K.C.2
-
6
-
-
33846050620
-
Dopamine D2-like receptors and the antidepressant response
-
Gershon AA, Vishne T, Grunhaus L: Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry 2007; 61:145-153
-
(2007)
Biol Psychiatry
, vol.61
, pp. 145-153
-
-
Gershon, A.A.1
Vishne, T.2
Grunhaus, L.3
-
7
-
-
34247544927
-
Potential utility of kappa ligands in the treatment of mood disorders
-
Edited by Dean RL III, Bilsky EJ, Negus SS III. Totowa, NJ, Humana Press in press
-
Carlezon WA Jr, Cohen BM: Potential utility of kappa ligands in the treatment of mood disorders, in Opioid Receptors and Antagonists: From Bench to Clinic. Edited by Dean RL III, Bilsky EJ, Negus SS III. Totowa, NJ, Humana Press (in press)
-
Opioid Receptors and Antagonists: From Bench to Clinic
-
-
Carlezon Jr, W.A.1
Cohen, B.M.2
-
8
-
-
33745793051
-
Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal
-
Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr: Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neuroscience 2006; 26: 6450-6457
-
(2006)
J Neuroscience
, vol.26
, pp. 6450-6457
-
-
Chartoff, E.H.1
Mague, S.D.2
Barhight, M.F.3
Smith, A.M.4
Carlezon Jr, W.A.5
|